Tandem Diabetes Care Inc (TNDM)
32.83
+0.92
(+2.88%)
USD |
NASDAQ |
Nov 04, 16:00
32.50
-0.33
(-1.01%)
After-Hours: 20:00
Tandem Diabetes Care Enterprise Value: 2.045B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 2.045B |
| November 01, 2024 | 1.985B |
| October 31, 2024 | 1.949B |
| October 30, 2024 | 2.014B |
| October 29, 2024 | 2.051B |
| October 28, 2024 | 2.039B |
| October 25, 2024 | 1.948B |
| October 24, 2024 | 1.975B |
| October 23, 2024 | 2.000B |
| October 22, 2024 | 2.091B |
| October 21, 2024 | 2.129B |
| October 18, 2024 | 2.209B |
| October 17, 2024 | 2.174B |
| October 16, 2024 | 2.350B |
| October 15, 2024 | 2.358B |
| October 14, 2024 | 2.341B |
| October 11, 2024 | 2.322B |
| October 10, 2024 | 2.261B |
| October 09, 2024 | 2.457B |
| October 08, 2024 | 2.506B |
| October 07, 2024 | 2.631B |
| October 04, 2024 | 2.631B |
| October 03, 2024 | 2.544B |
| October 02, 2024 | 2.591B |
| October 01, 2024 | 2.584B |
| Date | Value |
|---|---|
| September 30, 2024 | 2.672B |
| September 27, 2024 | 2.675B |
| September 26, 2024 | 2.781B |
| September 25, 2024 | 2.818B |
| September 24, 2024 | 2.870B |
| September 23, 2024 | 2.869B |
| September 20, 2024 | 2.817B |
| September 19, 2024 | 2.805B |
| September 18, 2024 | 2.687B |
| September 17, 2024 | 2.714B |
| September 16, 2024 | 2.691B |
| September 13, 2024 | 2.774B |
| September 12, 2024 | 2.760B |
| September 11, 2024 | 2.693B |
| September 10, 2024 | 2.580B |
| September 09, 2024 | 2.661B |
| September 06, 2024 | 2.671B |
| September 05, 2024 | 2.695B |
| September 04, 2024 | 2.587B |
| September 03, 2024 | 2.630B |
| August 30, 2024 | 2.743B |
| August 29, 2024 | 2.789B |
| August 28, 2024 | 2.801B |
| August 27, 2024 | 2.879B |
| August 26, 2024 | 2.796B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
717.62M
Minimum
Nov 10 2023
9.420B
Maximum
Dec 28 2021
4.063B
Average
3.542B
Median
Dec 17 2019
Enterprise Value Benchmarks
| Boston Scientific Corp | 133.49B |
| RxSight Inc | 1.800B |
| Perspective Therapeutics Inc | 530.78M |
| Xtant Medical Holdings Inc | 101.94M |
| Catheter Precision Inc | 2.064M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -30.81M |
| Revenue (Quarterly) | 221.91M |
| Total Expenses (Quarterly) | 252.68M |
| EPS Diluted (Quarterly) | -0.47 |
| Gross Profit Margin (Quarterly) | 50.83% |
| Profit Margin (Quarterly) | -13.89% |
| Earnings Yield | -6.37% |
| Normalized Earnings Yield | -6.319 |